The Claim
Urolithin A reduces fibrosis-related transcriptional reprogramming in human induced pluripotent stem cell-derived cardiomyocytes exposed to HFpEF-like stress conditions.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Urolithin A decreases changes in gene activity associated with heart muscle cell scarring under conditions mimicking heart failure with preserved ejection fraction.
See the scientific wording
Urolithin A attenuates fibrosis-related transcriptional reprogramming in human induced pluripotent stem cell-derived cardiomyocytes under HFpEF-like stress, suggesting a direct cardiomyocyte-intrinsic effect on preventing pathological cellular reprogramming.
Urolithin A triggers the cleanup of damaged mitochondria in heart cells, which improves their energy production and stops the cells from turning on scar-making genes. This keeps the heart cells functioning normally instead of becoming scar-like.
What the research says
1 studyIn lab-grown human heart cells under stress that mimics heart failure, a compound called urolithin A reduced the activity of genes that cause scarring. This means it directly helps heart cells stay healthy under stress.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.